| Literature DB >> 27242236 |
Sundeep Chowdhry1, Akhilesh Shukla2, Paschal D'souza1, Tapan Dhali1, Prashansa Jaiswal1.
Abstract
Erythema nodosum leprosum (ENL) is a common complication of lepromatous leprosy. Some patients unresponsive to conventional, first-line therapeutics develop recurrent, recalcitrant ENL. Here, we report a case of severe refractory ENL that was successfully treated with Etanercept. Biologics may be considered as therapeutic alternatives in management of severe, recalcitrant ENL.Entities:
Keywords: Biologics; Erythema nodosum leprosum; Etanercept; Leprosy; Treatment
Mesh:
Substances:
Year: 2016 PMID: 27242236 DOI: 10.1016/j.ijmyco.2016.02.002
Source DB: PubMed Journal: Int J Mycobacteriol ISSN: 2212-5531